Acute myocardial infarction in patients infected with human immunodeficiency virus

American Heart Journal

Volumn 147, Issue 1, 2004, Pages 55-59

  Varriale, Philip ^a,b   Saravi, Gonzalo ^a   Hernandez, Eliezer ^a   Carbon, Francisco ^a  

^a CABRINI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CORONARY RISK; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; ST SEGMENT ELEVATION; THORAX PAIN;

EID: 0347416933     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.07.007     Document Type: Article

References (46)

1. Currie PF, Jacob AJ, Foreman AR, et al. Heart muscle disease related to HIV infection: prognostic implications. BMJ 1994;309:1605-7.
2. Anderson DW, Virmani R, Reilly JM, et al. Prevalent myocarditis at necropsy in acquired immunodeficiency syndrome. J Am Coll Cardiol 1988;11:792-9.
3. Herskowitz A, Choou Wu T, Willoughby SB, et al. Myocarditis and cardiotropic viral infection associated with human immunodeficiency virus. J Am Coll Cardiol 1994;24:1025-32.
4. Jacob AJ, Sutherland GR, Bird AG, et al. Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J 1992;68:549-53.
5. Heidenreich PA, Eisenberg MJ, Kee LL. Pericardial effusions in AIDS: incidence and survival. Circulation 1995;92:3229-34.
6. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000;160:602-8.
7. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9.
8. Patel RC, Frishman W. Cardiac involvement in HIV infection. Med Clin North Am 1996;80:1493-512.
9. Lipshultz SE. Dilated cardiomyopathy in HIV-infected patients. N Engl J Med 1998;339:1153-5.
10. Moreno R, Villacastin JP, Bueno H, et al. Clinical and echocardiographic findings in HIV patients with pericardial effusion. Cardiology 1997;88:397-400.
11. Paton P, Tabib A, Loire R, Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993;144:225-31.
12. Joshi VV, Pawel B, Connor E, et al. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol 1987;7:261-75.
13. Constans J, Marchand JM, Conri C, et al. Asymptomatic atherosclerosis in HIV-positive patients: a case-control ultrasound study. Ann Med 1995;27:683-5.
14. Jabib A, Greenland T, Mercier I, Loire R, Momex JF. Coronary lesions in young HIV-positive subjects at necropsy [letter]. Lancet 1992;340:730.
15. Currier J, Boyd F, Burtcel B, et al. Accelerated atherosclerosis in men infected with human immunodeficiency virus [abstract]. Antiviral Ther 2001;6:36.
16. Behrens G, Schmidt H, Meyer D, Stoll M, Schmidt RE. Vascular complications associated with use of HIV protease inhibitors [letter]. Lancet 1998;351:1958.
17. Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors [letter]. Lancet 1998;351:1328.
18. Thomas EF, Lee AB. Myocardial Infarction in HIV-infected men receiving protease inhibitors [letter]. Ann Intern Med 1999;131:548.
19. Vittecog D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998;351:1959.
20. American Heart Association. 1999 Heart and stroke: statistical update. Dallas: American Heart Association; 1999.
21. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
22. Mocroft A, Youle M, Morcinek J, et al. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. BMJ 1997;314:409-13.
23. Monsuez JJ, Vittecog D, Kinney EL. Increased survival of AIDS patients with heart disease within 10 years? Circulation 1996;94:2312-3.
24. Enger C, Graham N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996;275:1329-34.
25. Matetzky S, Domingo M, Kar S, et al. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med 2003;163:457-60.
26. Hofman FM, Wright AD, Dohadwala MM, et al. Exogenous tat protein activates human endothelial cells. Blood 1993;82:2774-80.
27. Krishnaswamy G, Kelley J, Yerra L, et al. Human endothelium as a source of multifunctional cytokines: mollecular regulation and possible role in human disease. J Interferon Cytokine Res 1999;19:91-104.
28. Fiotti N, Giansante C, Ponte E, et al. Atherosclerosis and inflammation: patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999;145:51-60.
29. Chirivi RGS, Taraboletti G, Bani MR, et al. Human immunodeficiency virus-l-tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells. Blood 1999;94:1747-54.
30. Dhawan S, Puri RK, Kumar A, et al. Human immunodeficiency virus-l-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cells adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 1997;90:1535-44.
31. Zidovetzki R, Wang JL, Chen P, et al. Human immunodeficiency virus tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C and cAMP-dependent protein kinase pathways. AIDS Res Hum Retroviruses 1998;14:825-33.
32. Albini A, Benelli R, Giunciuglio D, et al. Identification of a novel domain of HIV tat involved in monocyte chemotaxis. J Biol Chem 1998;273:15895-900.
33. Lafrenie RM, Wahl LM, Epstein JS, et al. Activation of monocytes by HIV-tat treatment is mediated by cytokine expression. J Immunol 1997;159:4077-83.
34. Albini A, Soldi R, Giunciuglio D, et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 1996;2:1371-5.
35. Porsch-Oezcueruemez M, Kunz D, Kloer H, Luley C. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol 1999;34:1995-2001.
36. Oishi Y, Wakatsuki T, Nishikado A, Oki T, Ito S. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis 2000;11:77-81.
37. DeCaterina R, Basta G, Lazzerini G, et al. Soluble vascular cell adhesion molecule-1 as a a biohumeral correlates of atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:2646-54.
38. Pace GW, Leaf CD. The role of oxidative stress in HIV disease. Free Rad Biol Med 1995;19:523-8.
39. Zietz C, Hotz B, Sturzl M, et al. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am J Pathol 1996;149:1887-98.
40. Mitola S, Sozzani S, Luini W, et al. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 1997;90:1365-72.
41. Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction and natural course af HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.
42. Donner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 pprotease. N Engl J Med 1995;333:1528-33.
43. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease to treat HIV-1 infection. N Engl J Med 1999;333:1534-9.
44. Sullivan AK, Nelson MR. Marked hyperlipidaemia on ritonavir therapy. AIDS 1997;11:938-9.
45. Tsiodras S, Mantzoros C, Hammer S, Samore M. Effect of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy. Arch Intern Med 2000;160:2050-6.
46. Bozette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-10.